Immunity & Ageing (Mar 2024)

Excess of body weight is associated with accelerated T-cell senescence in hospitalized COVID-19 patients

  • Mailton Prestes Madruga,
  • Lucas Kich Grun,
  • Letícya Simone Melo Dos Santos,
  • Frederico Orlando Friedrich,
  • Douglas Bitencourt Antunes,
  • Marcella Elesbão Fogaça Rocha,
  • Pedro Luis Silva,
  • Gilson P. Dorneles,
  • Paula Coelho Teixeira,
  • Tiago Franco Oliveira,
  • Pedro R.T. Romão,
  • Lucas Santos,
  • José Claudio Fonseca Moreira,
  • Vinicius Schenk Michaelsen,
  • Marcelo Cypel,
  • Marcos Otávio Brum Antunes,
  • Marcus Herbert Jones,
  • Florencia María Barbé-Tuana,
  • Moisés Evandro Bauer

DOI
https://doi.org/10.1186/s12979-024-00423-6
Journal volume & issue
Vol. 21, no. 1
pp. 1 – 17

Abstract

Read online

Abstract Background Several risk factors have been involved in the poor clinical progression of coronavirus disease-19 (COVID-19), including ageing, and obesity. SARS-CoV-2 may compromise lung function through cell damage and paracrine inflammation; and obesity has been associated with premature immunosenescence, microbial translocation, and dysfunctional innate immune responses leading to poor immune response against a range of viruses and bacterial infections. Here, we have comprehensively characterized the immunosenescence, microbial translocation, and immune dysregulation established in hospitalized COVID-19 patients with different degrees of body weight. Results Hospitalised COVID-19 patients with overweight and obesity had similarly higher plasma LPS and sCD14 levels than controls (all p < 0.01). Patients with obesity had higher leptin levels than controls. Obesity and overweight patients had similarly higher expansions of classical monocytes and immature natural killer (NK) cells (CD56+CD16−) than controls. In contrast, reduced proportions of intermediate monocytes, mature NK cells (CD56+CD16+), and NKT were found in both groups of patients than controls. As expected, COVID-19 patients had a robust expansion of plasmablasts, contrasting to lower proportions of major T-cell subsets (CD4 + and CD8+) than controls. Concerning T-cell activation, overweight and obese patients had lower proportions of CD4+CD38+ cells than controls. Contrasting changes were reported in CD25+CD127low/neg regulatory T cells, with increased and decreased proportions found in CD4+ and CD8+ T cells, respectively. There were similar proportions of T cells expressing checkpoint inhibitors across all groups. We also investigated distinct stages of T-cell differentiation (early, intermediate, and late-differentiated – TEMRA). The intermediate-differentiated CD4 + T cells and TEMRA cells (CD4+ and CD8+) were expanded in patients compared to controls. Senescent T cells can also express NK receptors (NKG2A/D), and patients had a robust expansion of CD8+CD57+NKG2A+ cells than controls. Unbiased immune profiling further confirmed the expansions of senescent T cells in COVID-19. Conclusions These findings suggest that dysregulated immune cells, microbial translocation, and T-cell senescence may partially explain the increased vulnerability to COVID-19 in subjects with excess of body weight.

Keywords